SCHEMBL2270146

SCHEMBL2270146

COc1ccc(-c2ccc(C(=O)O)c(NC(=O)c3ccccc3)c2)cc1OC

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHEK1 O14757 1/20 0.67
PIM1 P11309 1/20 0.67
MAPK8 P45983 1/20 0.67
CLK4 Q9HAZ1 1/20 0.67
KDM4E B2RXH2 4/20 0.62
MAPK1 P28482 1/20 0.62
HSD17B10 Q99714 1/20 0.62
APAF1 O14727 1/20 0.59
RECQL P46063 1/20 0.59
CASP6 P55212 1/20 0.59
CACNA1B Q00975 1/20 0.59
APBA1 Q02410 1/20 0.59
MCL1 Q07820 1/20 0.59
CASP8 Q14790 1/20 0.59
AAK1 Q2M2I8 1/20 0.58
AKR1C4 P17516 1/20 0.57
AKR1C3 P42330 1/20 0.57
AKR1C2 P52895 1/20 0.57
AKR1C1 Q04828 1/20 0.57
ACLY P53396 2/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2271453 0.89 KMT2A (0.69) CHEK1PIM1MAPK8CLK4KDM4E
SCHEMBL27848589 0.89 ACLY (0.59) CHEK1PIM1MAPK8CLK4KDM4E
SCHEMBL2273065 0.86 MAPK1 (0.57) CHEK1PIM1MAPK8CLK4KDM4E
SCHEMBL2275393 0.86 HDAC2 (0.73) KDM4EACLYKMT2AMEN1ALDH1A1
SCHEMBL14907131 0.84 KDM4E (0.81) CHEK1PIM1MAPK8CLK4KDM4E
SCHEMBL2271137 0.84 HDAC2 (0.74) ACLYKMT2AMEN1ALDH1A1NPC1
SCHEMBL2276597 0.83 MEN1 (0.61) CHEK1PIM1MAPK8CLK4KDM4E
SCHEMBL2275453 0.83 ACLY (0.76) ACLYKMT2AMEN1NPC1RAB9A
SCHEMBL2269165 0.82 MEN1 (0.69) KDM4EACLYKMT2AMEN1ALDH1A1
SCHEMBL4563581 0.81 ACLY (0.65) MCL1ACLYKMT2AMEN1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7999132-B2 Anthranilic acid derivative or salt thereof TOYAMA CHEMICAL CO., LTD. (JP) 2011-08-16 US disclosed
US-7999132-B2 Anthranilic acid derivative or salt thereof TOYAMA CHEMICAL CO., LTD. (JP) 2011-08-16 US disclosed
US-20090240052-A1 NOVEL ANTHRANILIC ACID DERIVATIVE OR SALT THEREOF TOYAMA CHEMICAL CO., LTD. (JP) 2009-09-24 US disclosed
US-20090240052-A1 NOVEL ANTHRANILIC ACID DERIVATIVE OR SALT THEREOF TOYAMA CHEMICAL CO., LTD. (JP) 2009-09-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090240052-A1 NOVEL ANTHRANILIC ACID DERIVATIVE OR SALT THEREOF MMP13, MMP26, MMP11 CHEK1 4352/4885PIM1 4707/4885MAPK8 648/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.